Skip to content
PeptideSport

MEDVidi

Telehealth provider · directory record

Price on record

No medication price published. We could not find a figure this provider publishes for the drug itself — which is a finding about the provider, not a gap in our data.

What it is

MEDVidi is a US telehealth platform whose licensed providers evaluate patients and prescribe GLP-1 weight-management medications, including brand-name Zepbound (tirzepatide) and Wegovy (semaglutide), plus Saxenda, Qsymia and phentermine. It runs on a per-visit consult model rather than a bundled subscription: an initial appointment is 195 dollars and a follow-up is 159 dollars, and prescriptions g

Coverage

Coverage not published

Peptides on record

None recorded beyond GLP-1s

On record for

  • Licensed providers can prescribe brand-name Zepbound and Wegovy
  • Transparent flat consultation fees (195 dollar initial, 159 dollar follow-up)
  • Prescriptions sent to the patient's pharmacy of choice, so insurance can be used

On record against

  • Consult-fee model: medication is not included and its cost is separate
  • No medication pricing is published
  • State list is shown as a map rather than enumerated
Visit MEDVidi

We earn a commission if you start care through some of these links, at no extra cost to you. See our disclosure.

Other providers in the directory

The providers we have researched in depth are on our reviews index, and the ones we rank are on our sermorelin board and our NAD+ board.